Vera Therapeutics, Inc. (VERA)

Vera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	49.12	92.65	45.68	43.46	79.67	53.65
Short-Term Investments	507.71	548.21	115.04	71.19	-	0.09
Cash & Short-Term Investments	556.83	640.85	160.72	114.65	79.67	53.74
Cash Growth	44.86%	298.75%	40.18%	43.90%	48.26%	1564.29%
Other Receivables	4.2	3.77	0.51	-	-	0.05
Receivables	4.2	3.77	0.51	-	-	0.05
Prepaid Expenses	8.7	5.68	8.56	10.33	2.38	0.03
Restricted Cash	-	-	-	-	-	0.05
Other Current Assets	1.62	0.91	2.24	0.72	0.48	0.39
Total Current Assets	571.35	651.22	172.02	125.7	82.54	54.26
Property, Plant & Equipment	3.62	4.33	3.04	5.22	-	-
Long-Term Investments	-	-	-	0.06	0.87	-
Other Long-Term Assets	3.55	0.13	0.48	0.46	0.34	0.29
Total Assets	578.53	655.68	175.55	131.44	83.75	54.55
Accounts Payable	13.16	7.67	11.12	11.99	1.39	0.91
Accrued Expenses	19.54	16.22	8.75	10.96	5.93	0.54
Current Portion of Leases	0.86	1.48	2.44	2.65	-	-
Other Current Liabilities	-	-	-	-	0.38	0.96
Total Current Liabilities	33.55	25.37	22.3	25.6	7.69	2.41
Long-Term Debt	74.46	50.69	49.88	24.81	4.92	-
Long-Term Leases	2.23	2.47	1.4	3.83	-	-
Other Long-Term Liabilities	-	-	0.29	0.29	1.54	1.92
Total Liabilities	110.25	78.53	73.86	54.53	14.16	4.33
Common Stock	0.06	0.06	0.04	0.03	0.02	-
Additional Paid-In Capital	1,057	1,038	410.49	290.22	193.63	2.1
Retained Earnings	-589.48	-461.25	-309.1	-213.11	-124.06	-91.45
Comprehensive Income & Other	0.53	0.39	0.25	-0.22	-	-
Total Common Equity	468.28	577.16	101.69	76.91	69.59	-89.35
Shareholders' Equity	468.28	577.16	101.69	76.91	69.59	50.23
Total Liabilities & Equity	578.53	655.68	175.55	131.44	83.75	54.55
Total Debt	77.55	54.64	53.71	31.29	4.92	-
Net Cash (Debt)	479.28	586.21	107.01	83.37	74.75	53.74
Net Cash Growth	44.55%	447.82%	28.36%	11.53%	39.10%	1635.23%
Net Cash Per Share	7.89	10.60	2.51	3.14	5.56	167.96
Filing Date Shares Outstanding	63.82	63.75	54.45	44.26	27.05	0.36
Total Common Shares Outstanding	63.82	63.56	44.45	27.8	21.28	0.36
Working Capital	537.8	625.85	149.72	100.1	74.85	51.86
Book Value Per Share	7.34	9.08	2.29	2.77	3.27	-251.47
Tangible Book Value	468.28	577.16	101.69	76.91	69.59	-89.35
Tangible Book Value Per Share	7.34	9.08	2.29	2.77	3.27	-251.47

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q